Skip to main content
Data show positive results for Endologix's abdominal stent graft system

Thirty-day data from a 225-patient trial showed use of Endologix's Ovation abdominal stent graft system led to at least 28% more women becoming eligible for minimally invasive endovascular aneurysm repair. The adverse event rate for the device was 1.3%, with a 3.9% readmission rate and no deaths, limb occlusion or proximal endoleaks.

Full Story: